Quartet Medicine is a private, biotechnology company focused on discovering and developing novel treatments for chronic pain and inflammation. Human genetics and preclinical target validation data point to increased tetrahydrobiopterin (BH4) as a critical mediator of peripheral nerve dysfunction and immune cell regulation. Quartet is capitalizing on these insights by safely restoring BH4 homeostasis in neuronal and inflammatory cells.
Quartet was founded by scientists at Boston Children’s Hospital and École Polytechnique Fédérale de Lausanne (EPFL) in Switzerland in conjunction with Atlas Venture. Quartet’s Series A investors include Atlas Venture, Novartis Venture Funds, Pfizer Venture Investments and Partners Innovation Fund. The company is based in Cambridge, Massachusetts and has research efforts underway with collaborators in the US, Europe and Asia.
Company Details
- Founded
- -
- Address
- 222 Third Street, Suite 1100, Cambridge,massachusetts 02142,united States
- Industry
- Biotechnology
- Website
- http://quartetmedicine.com
- Keywords
- Springfield.
- HQ
- Cambridge, Massachusetts
Quartet Medicine Questions
Quartet Medicine's website is http://quartetmedicine.com
Quartet Medicine's LinkedIn profile is https://www.linkedin.com/company/quartetmedicine
Quartet Medicine's industry is
Biotechnology
Quartet Medicine's top competitors are
Paredox Therapeutics Llc,
Nextcea, Inc.,
Nemucore Medical Innovations, Inc.,
One Biotech Inc,
Outlier Biopharma,
Niviron Inc.,
Paros Bio,
Pioneer Valley Life Sciences Institute,
Oriel Research Therapeutics (Ort),
Pharmask.
Quartet Medicine's categories are Biotechnology
Quartet Medicine's founding year is 1996
